A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements.

J. Riess,S. Padda,C. Bangs,M. Das,J. Neal,A. Adrouny,A. Cherry,H. Wakelee
DOI: https://doi.org/10.1016/j.cllc.2013.04.008
IF: 4.84
2013-09-01
Clinical Lung Cancer
Abstract:
What problem does this paper attempt to address?